Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.75 and traded as high as $0.96. Mesoblast shares last traded at $0.91, with a volume of 600 shares traded.
Mesoblast Price Performance
The company’s fifty day moving average price is $0.79 and its 200 day moving average price is $0.75.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- How to Invest in the Best Canadian Stocks
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What Are Dividend Contenders? Investing in Dividend Contenders
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is the Hang Seng index?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
